What is the appropriate griseofulvin (125 mg/5 ml suspension) dosage for a child weighing 46.45 kg?

Griseofulvin Dosing for a 46.45 kg Child

For a child weighing 46.45 kg, administer griseofulvin 15-20 mg/kg/day (approximately 700-930 mg daily or 28-37 mL of the 125 mg/5 mL suspension), given as a single dose or divided doses, for 6-8 weeks. 1

Weight-Based Dosing Algorithm

Since this child weighs 46.45 kg (under 50 kg), the British Association of Dermatologists guidelines clearly specify:

• Standard dose: 15-20 mg/kg/day for 6-8 weeks 1
• Calculation for this patient:
  • Lower range: 15 mg/kg × 46.45 kg = 697 mg/day (approximately 28 mL)
  • Upper range: 20 mg/kg × 46.45 kg = 929 mg/day (approximately 37 mL)

The FDA label for griseofulvin suspension confirms pediatric dosing of 10 mg/kg daily is usually adequate, with children over 50 lbs receiving 250-500 mg daily 2. However, prioritize the higher guideline-recommended range of 15-20 mg/kg/day as this reflects current best practice and achieves better clinical outcomes 1.

Practical Dosing Recommendations

Start with 20 mg/kg/day (approximately 930 mg or 37 mL daily) given the following considerations:

• Higher doses within the licensed range improve efficacy, particularly for resistant cases 1
• Recent evidence shows doses up to 30 mg/kg/day may be necessary for complete response in some populations, particularly with Trichophyton species 3
• The standard licensed protocol allows up to 25 mg/kg/day for resistant cases 1

Dosing can be given:

• As a single daily dose (37 mL once daily), OR
• Divided into two doses (18.5 mL twice daily)

Critical Administration Details

• Give with fatty food to enhance absorption and improve bioavailability 1, 2
• Studies show administration with milk increases peak serum concentrations 4-fold and area under the curve 10-fold in pediatric patients 2
• Treatment duration: 6-8 weeks minimum for tinea capitis 1

Species-Specific Considerations

Griseofulvin is most effective for Microsporum species (88.5% response rate) compared to Trichophyton species (67.9% response rate) 1. If the causative organism is:

• Microsporum canis/audouinii: Griseofulvin is first-line; 8 weeks treatment significantly more effective than terbinafine 1
• Trichophyton species: May require higher doses (up to 25 mg/kg/day) and longer duration (12-18 weeks) 1

Treatment Failure Protocol

If inadequate response after 6-8 weeks 1:

1. First assess: compliance, drug absorption (ensure taking with fatty food), reinfection
2. If clinical improvement but positive mycology: Continue current dose for additional 2-4 weeks
3. If no clinical improvement: Increase to 25 mg/kg/day (up to 1,160 mg or 46 mL daily) 1
4. Consider second-line: Switch to itraconazole if griseofulvin fails at maximum dose

Safety Monitoring

While mild laboratory abnormalities occur in approximately 20% of pediatric patients, significant abnormalities requiring treatment discontinuation are extremely rare (0.8%) 4. The drug is generally well-tolerated in children with over 50 years of safety data 1.

Contraindications to verify: lupus erythematosus, porphyria, severe liver disease 1

Drug interactions: Rifampicin decreases plasma concentration; cimetidine increases it 1

Common Pitfall to Avoid

Do not underdose. The FDA label mentions 10 mg/kg/day, but current guidelines and clinical practice support 15-20 mg/kg/day for optimal efficacy 1. Recent evidence suggests even higher doses (up to 30 mg/kg/day) may be necessary for complete response in certain populations 3. Starting at the higher end of the recommended range (20 mg/kg/day) maximizes treatment success while remaining within licensed dosing parameters.